Intrexon Researching Diabetes For Janssen

Maryland-based biotech Intrexon Corp. inked an early research collaboration with Janssen Pharmaceutica NV to develop treatments for type 2 diabetes and other metabolic disorders, including obesity.

The deal was brokered by the big pharma's recently established business development engine Johnson & Johnson Innovation. The Centers of...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Alimentary/Metabolic

More from Therapeutic Category